The efficacy of an extract obtained from the non-edible parts of pomegranates.
Additional drugmakers flag risks of working with WuXi amid heightened US scrutiny
More drug companies are disclosing the potential for clinical trial delays and drug shortages if the US government blacklists a family of WuXi companies used